ЛИПП Майкл М. (US),КЛАРК Роберт В. (US),ХЭВА Дэвид Л. (US),БЭТИКИ Ричард (US),ХЭНРЭХЭН Джон (US)
申请号：
RU2011137961/15
公开号：
RU2011137961A
申请日:
2010.03.26
申请国别(地区):
RU
年份:
2013
代理人:
摘要：
1. A pharmaceutical composition comprising a calcium salt and a sodium salt, wherein the Sac Na ratio is from about 4: 1 (mol: mol) to about 16: 1 (mol: mol) .2. The pharmaceutical composition according to claim 1, wherein the Sac Na ratio is approximately 4: 1 (mol: mol). The pharmaceutical composition according to claim 1, wherein the Sac Na ratio is approximately 5: 1 (mol: mol). The pharmaceutical composition according to claim 1, wherein the Sac Na ratio is approximately 6: 1 (mol: mol). The pharmaceutical composition according to claim 1, wherein the Sac Na ratio is approximately 7: 1 (mol: mol). The pharmaceutical composition according to claim 1, wherein the Sac Na ratio is approximately 8: 1 (mol: mol). The pharmaceutical composition according to claim 1, wherein the Sac Na ratio is approximately 9: 1 (mol: mol). The pharmaceutical composition according to claim 1, wherein the Sac Na ratio is approximately 10: 1 (mol: mol). The pharmaceutical composition according to claim 1, wherein the Sac Na ratio is approximately 11: 1 (mol: mol). The pharmaceutical composition of claim 1, wherein the Sac Na ratio is approximately 12: 1 (mol: mol). The pharmaceutical composition of claim 1, wherein the Sac Na ratio is approximately 13: 1 (mol: mol). The pharmaceutical composition of claim 1, wherein the Sac Na ratio is approximately 14: 1 (mol: mol). The pharmaceutical composition of claim 1, wherein the Sac Na ratio is approximately 15: 1 (mol: mol). The pharmaceutical composition of claim 1, wherein the Sac Na ratio is approximately 16: 1 (mol: mol). The pharmaceutical composition of claim 1, wherein the pharmaceutical composition is a liquid composition. The pharmaceutical composition of claim 15, wherein the Ca ion is present in a concentration of from about 0.115 M to about 1.15 M. The pharmaceutical composition of claim 15, wherein1. Фармацевтический состав, включающий соль кальция и соль натрия, в котором отношение Сак Naравно от приблизительно 4:1 (моль:моль) до
